News

Seeing Ryland

For Hillary Whittington ’04, facilitating her young son Ryland’s gender transition also changed her in ways she could never have imagined. Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Illumina Files Preliminary Proxy, Urging Shareholders to Vote for Its Director Nominees and Withhold for Each Icahn Group Nominee

SAN DIEGO, March 30, 2023 /PRNewswire/ — Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today filed its preliminary proxy statement with the Securities and Exchange Commission, which contains important information […]

No Picture
News

Lineage and the Christopher & Dana Reeve Foundation Proudly Present the 1st Annual Spinal Cord Injury Investor Symposium

CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, and the Christopher & Dana Reeve Foundation, a non-profit organization […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Sorrento Therapeutics, Inc. Receives Final Court Approval for $75 Million Debtor-In-Possession Financing

SAN DIEGO, March 29, 2023 /PRNewswire/ — Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento”), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, today announced that the […]

News

Dissecting the Circadian Clock in Real Time

Researchers have advanced our understanding of the circadian clock, the biological cycle that synchronizes with light-dark exposure. They recently developed a method to study how the circadian clock synchronizes with the environment in real time, […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

New data presented at AD/PD™2023 show IONIS-MAPT Rx (BIIB080) substantially reduced tau protein in patients with early-stage Alzheimer’s disease

Phase 1b study showed dose-dependent and sustained reduction of tau protein in cerebrospinal fluid through open-label long-term extension (LTE) IONIS-MAPTRx reduced aggregated tau pathology across all brain composites assessed starting as early as week 25 […]

No Picture
News

Wugen to Present Data on WU-NK-101 at the American Association for Cancer Research (AACR) Annual Meeting 2023

ST. LOUIS & SAN DIEGO–(BUSINESS WIRE)–Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of allogeneic cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced an upcoming presentation highlighting […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

MedCrypt Joins Microsoft Azure Marketplace Offering One of the Only Cryptography Tools with an API Specifically Designed for Medical Devices

Azure customers worldwide now have access to MedCrypt’s cryptography API solution, Guardian, which allows manufacturers to build cryptography directly into medical devices SAN DIEGO, March 28, 2023 /PRNewswire/ — MedCrypt, Inc., the proactive cybersecurity solution […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Cardiff Oncology Announces First Patient Dosed in ONSEMBLE Phase 2 Randomized Trial of Onvansertib in Patients with Metastatic Colorectal Cancer

SAN DIEGO, March 28, 2023 /PRNewswire/ — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers, today announced […]

ADVERTISEMENT — Advertise With Biotech Networks
ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Illumina launches new software to enable tertiary analysis for oncology applications, and soon rare disease

As demand for clinical next-generation sequencing grows, Illumina Connected Insights enables user to streamline data interpretation and report generation to inform precision care SAN DIEGO, March 27, 2023 /PRNewswire/ — Illumina Inc. (NASDAQ: ILMN), a […]